.Pharmacolibrary.Drugs.S_SensoryOrgans.S01E_AntiglaucomaPreparationsAndMiotics.S01EC04_Brinzolamide.Brinzolamide .Pharmacolibrary.Drugs.S_SensoryOrgans.S01E_AntiglaucomaPreparationsAndMiotics.S01EC04_Brinzolamide.Brinzolamide| name: | Brinzolamide | |
| ATC code: | S01EC04 | |
| route: | ophthalmic | |
| compartments: | 1 | |
| dosage: | 1 | mg |
| volume of distribution: | 7.6 | L |
| clearance: | 0.13 | L/h |
| other parameters in model implementation | ||
Brinzolamide is a topical carbonic anhydrase inhibitor used for the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. It is approved for ophthalmic use and lowers intraocular pressure by reducing aqueous humor formation.
Pharmacokinetic parameters reported for healthy adults after ophthalmic (topical) administration.